| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.0082 | 1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |